Difference between revisions of "Degradation Pathways"
| Line 17: | Line 17: | ||
| style="text-align: center;" | 44 | | style="text-align: center;" | 44 | ||
| style="text-align: center;" | exPGF2a | | style="text-align: center;" | exPGF2a | ||
| − | | style="text-align: center;" | | + | | style="text-align: center;" | 900 ± 492 |
| − | | style="text-align: center;" | 0. | + | | style="text-align: center;" | 0.001 ± 0.001 |
| style="text-align: center;" |Study performed in decidual stromal cells and macrophages in culture. | | style="text-align: center;" |Study performed in decidual stromal cells and macrophages in culture. | ||
| style="text-align: center;" | <ref name="Ishihara1991”>[http://www.ncbi.nlm.nih.gov/pubmed/1789996 O. Ishihara, "Differences of metabolism of prostaglandin E2 and F2 alpha by decidual stromal cells and macrophages in culture." Eicosanoids. 1991;4(4):203-7.]</ref> | | style="text-align: center;" | <ref name="Ishihara1991”>[http://www.ncbi.nlm.nih.gov/pubmed/1789996 O. Ishihara, "Differences of metabolism of prostaglandin E2 and F2 alpha by decidual stromal cells and macrophages in culture." Eicosanoids. 1991;4(4):203-7.]</ref> | ||
| Line 38: | Line 38: | ||
| style="text-align: center;" | 47 | | style="text-align: center;" | 47 | ||
| style="text-align: center;" | ex6-KETO-PGF2A | | style="text-align: center;" | ex6-KETO-PGF2A | ||
| − | | style="text-align: center;" | | + | | style="text-align: center;" | |
| − | | style="text-align: center;" | | + | | style="text-align: center;" | |
| style="text-align: center;" |Quoted in a textbook(https://books.google.co.uk/books?id=_9kEeTjyJdMC&pg=PA864&lpg=PA864&dq=half+life+txa2&source=bl&ots=2OTF4Mh2Jk&sig=hu79GprliUcW4QE_Zm79islesOA&hl=en&sa=X&ved=0ahUKEwj0oo2sgfjOAhXLIcAKHcaPDHQQ6AEIRjAI#v=onepage&q=half%20life%20txa2&f=false) with no ref. | | style="text-align: center;" |Quoted in a textbook(https://books.google.co.uk/books?id=_9kEeTjyJdMC&pg=PA864&lpg=PA864&dq=half+life+txa2&source=bl&ots=2OTF4Mh2Jk&sig=hu79GprliUcW4QE_Zm79islesOA&hl=en&sa=X&ved=0ahUKEwj0oo2sgfjOAhXLIcAKHcaPDHQQ6AEIRjAI#v=onepage&q=half%20life%20txa2&f=false) with no ref. | ||
| style="text-align: center;" | | | style="text-align: center;" | | ||
| Line 45: | Line 45: | ||
| style="text-align: center;" | 48 | | style="text-align: center;" | 48 | ||
| style="text-align: center;" | exPGI2 | | style="text-align: center;" | exPGI2 | ||
| − | | style="text-align: center;" | | + | | style="text-align: center;" | 3 |
| − | | style="text-align: center;" | 0. | + | | style="text-align: center;" | 0.231 |
| style="text-align: center;" | | | style="text-align: center;" | | ||
| style="text-align: center;" |<ref name="Cawello1994”>[https://www.ncbi.nlm.nih.gov/pubmed/8070511 Cawello W., "Metabolism and pharmacokinetics of prostaglandin E1 administered by intravenous infusion in human subjects." Eur J Clin Pharmacol. 1994;46(3):275-7.]</ref> | | style="text-align: center;" |<ref name="Cawello1994”>[https://www.ncbi.nlm.nih.gov/pubmed/8070511 Cawello W., "Metabolism and pharmacokinetics of prostaglandin E1 administered by intravenous infusion in human subjects." Eur J Clin Pharmacol. 1994;46(3):275-7.]</ref> | ||
| Line 52: | Line 52: | ||
| style="text-align: center;" | 49 | | style="text-align: center;" | 49 | ||
| style="text-align: center;" | exPGE2 | | style="text-align: center;" | exPGE2 | ||
| − | | style="text-align: center;" | | + | | style="text-align: center;" | 528 ± 204 |
| − | | style="text-align: center;" | 0. | + | | style="text-align: center;" | 0.001 ± 0.003 |
| style="text-align: center;" | Study performed in decidual stromal cells and macrophages in culture. | | style="text-align: center;" | Study performed in decidual stromal cells and macrophages in culture. | ||
| style="text-align: center;" | <ref name="Ishihara1991”>[http://www.ncbi.nlm.nih.gov/pubmed/1789996 O. Ishihara, "Differences of metabolism of prostaglandin E2 and F2 alpha by decidual stromal cells and macrophages in culture." Eicosanoids. 1991;4(4):203-7.]</ref> | | style="text-align: center;" | <ref name="Ishihara1991”>[http://www.ncbi.nlm.nih.gov/pubmed/1789996 O. Ishihara, "Differences of metabolism of prostaglandin E2 and F2 alpha by decidual stromal cells and macrophages in culture." Eicosanoids. 1991;4(4):203-7.]</ref> | ||
| Line 76: | Line 76: | ||
| style="text-align: center;" | 0.462 to 0.433 | | style="text-align: center;" | 0.462 to 0.433 | ||
| style="text-align: center;" | Human brain | | style="text-align: center;" | Human brain | ||
| − | | style="text-align: center;" | <ref name=" | + | | style="text-align: center;" | <ref name="Schuligoi2007”>[http://www.sciencedirect.com/science/article/pii/S0006295207001918?via%3Dihub R. Schuligoi. "PGD2 metabolism in plasma: Kinetics and relationship with bioactivity on DP1 and CRTH2 receptors" Biochemical Pharmacology, Volume 74, Issue 1, 30 June 2007, Pages 107-117]</ref> |
|- | |- | ||
| style="text-align: center;" | 53 | | style="text-align: center;" | 53 | ||
Revision as of 10:38, 15 June 2017
Upon being transported out of the cell, the eicosanoids accumulate in the interstitial fluid, which for simplicity is referred to as the extracellular compartment in the model. A decay constant was included for each extracellular metabolite to represent degradation. To describe the breaking down of metabolites an irreversible mass action rate law was used for reactions 43-64. The half life of each eicosanoid was initially assumed as 24 hours, but will be made metabolite specific when all of the values have been collected.
Pseudo-first order reactions.
| Reaction # | Species | Half Life (min) | Rate constant(min -1) | Notes | Reference |
|---|---|---|---|---|---|
| 44 | exPGF2a | 900 ± 492 | 0.001 ± 0.001 | Study performed in decidual stromal cells and macrophages in culture. | [1] |
| 45 | exTXB2 | 20 to 30 | 0.035 to 0.023 | Quoted in a textbook(https://books.google.co.uk/books?id=_9kEeTjyJdMC&pg=PA864&lpg=PA864&dq=half+life+txa2&source=bl&ots=2OTF4Mh2Jk&sig=hu79GprliUcW4QE_Zm79islesOA&hl=en&sa=X&ved=0ahUKEwj0oo2sgfjOAhXLIcAKHcaPDHQQ6AEIRjAI#v=onepage&q=half%20life%20txa2&f=false) with no ref. | |
| 46 | exTXA2 | 0.333 | 2.079 | Quoted in a textbook(https://books.google.co.uk/books?id=_9kEeTjyJdMC&pg=PA864&lpg=PA864&dq=half+life+txa2&source=bl&ots=2OTF4Mh2Jk&sig=hu79GprliUcW4QE_Zm79islesOA&hl=en&sa=X&ved=0ahUKEwj0oo2sgfjOAhXLIcAKHcaPDHQQ6AEIRjAI#v=onepage&q=half%20life%20txa2&f=false) with no ref. | |
| 47 | ex6-KETO-PGF2A | Quoted in a textbook(https://books.google.co.uk/books?id=_9kEeTjyJdMC&pg=PA864&lpg=PA864&dq=half+life+txa2&source=bl&ots=2OTF4Mh2Jk&sig=hu79GprliUcW4QE_Zm79islesOA&hl=en&sa=X&ved=0ahUKEwj0oo2sgfjOAhXLIcAKHcaPDHQQ6AEIRjAI#v=onepage&q=half%20life%20txa2&f=false) with no ref. | |||
| 48 | exPGI2 | 3 | 0.231 | [2] | |
| 49 | exPGE2 | 528 ± 204 | 0.001 ± 0.003 | Study performed in decidual stromal cells and macrophages in culture. | [1] |
| 50 | ex15-DEOXY-PGJ2 | 720 | 0.001 | Dehydration of PGD2 to ultimatley 15d-PGJ2 occurs with a half life of about 12 hours in the presense of albumin (protien found in blood). | [3] |
| 51 | exPGJ2 | ||||
| 52 | exPGD2 | 1.5 - 1.6 | 0.462 to 0.433 | Human brain | [4] |
| 53 | exPGH2 | 5 | 0.139 | Quoted on supplier page (http://www.enzolifesciences.com/BML-PH002/prostaglandin-h2/) | |
| 54 | ex5-OXO-ETE | 11 | 0.064 | Study in R15L Cells | [5] |
| 55 | ex5-HETE | ||||
| 56 | exLTB4 | 0.47 ± 0.02 to 0.63 ± 0.04 | 1.475 ± 34.657 to 1.100 ± 17.329 | Rabbit, Immunoreactive LTB4 | [6] |
| 57 | exLTC4 | ||||
| 58 | exLTA4 | 0.05 | 13.863 | 37 degrees C | [7] |
| 59 | ex5-HPETE | ||||
| 60 | ex15-HETE | 21 | 0.0331 | Study in R15L Cells | [5] |
| 61 | ex15-HPETE | ||||
| 62 | ex12-HETE | 180 | 0.004 | "During the first 2 min., the half-life of 12-HETE was 0.9 s, which implies
a fast clearance of the compound from the circulation. However, during the subsequent half-hour the estimated half-life was 3 min. and increased dramatically at the interval of time from 30 to 60 min. (t1/2 around 3 h)." |
[8] |
| 63 | ex12-HPETE | 0.5 | 1.386 | [9] | |
| 64 | exAA | 240 to 660 | 0.003 to 0.001 | [10] |
References
- ↑ 1.0 1.1 O. Ishihara, "Differences of metabolism of prostaglandin E2 and F2 alpha by decidual stromal cells and macrophages in culture." Eicosanoids. 1991;4(4):203-7.
- ↑ Cawello W., "Metabolism and pharmacokinetics of prostaglandin E1 administered by intravenous infusion in human subjects." Eur J Clin Pharmacol. 1994;46(3):275-7.
- ↑ F. Fitzpatrick, "Albumin-catalyzed metabolism of prostaglandin D2. Identification of products formed in vitro." J Biol Chem. 1983 Oct 10;258(19):11713-8.
- ↑ R. Schuligoi. "PGD2 metabolism in plasma: Kinetics and relationship with bioactivity on DP1 and CRTH2 receptors" Biochemical Pharmacology, Volume 74, Issue 1, 30 June 2007, Pages 107-117
- ↑ 5.0 5.1 Cong W., "15-oxo-Eicosatetraenoic Acid, a Metabolite of Macrophage 15-Hydroxyprostaglandin Dehydrogenase That Inhibits Endothelial Cell Proliferation" Mol Pharmacol. 2009 Sep; 76(3): 516–525.
- ↑ Marleau S., "Metabolic disposition of leukotriene B4 (LTB4) and oxidation-resistant analogues of LTB4 in conscious rabbits." Br J Pharmacol. 1994 Jun;112(2):654-8.
- ↑ Zimmer J., "Fatty acid binding proteins stabilize leukotriene A4 competition with arachidonic acid but not other lipoxygenase products" November 2004 The Journal of Lipid Research, 45, 2138-2144.
- ↑ Dadaian M., "12-hydroxyeicosatetraenoic acid is a long-lived substance in the rabbit circulation." Prostaglandins Other Lipid Mediat. 1998 Jan;55(1):3-25.
- ↑ J. Maclouf, "Stimulation of leukotriene biosynthesis in human blood leukocytes by platelet-derived 12-hydroperoxy-icosatetraenoic acid" (1982) Proc. Natl. Acad. Sci. U. S. A. 79, 6042-6046
- ↑ Vinge E., "Arachidonic acid-induced platelet aggregation and prostanoid formation in whole blood in relation to plasma concentration of indomethacin." Eur J Clin Pharmacol. 1985;28(2):163-9.
